Description
All oral, fixed-duration ibrutinib + venetoclax leads to long treatment-free remissions in patients with previously untreated CLL/SLL
Article: All oral, fixed-duration ibrutinib + venetoclax leads to long treatment-free remissions in patients with previously untreated CLL/SLL
€3.03
Reviews
There are no reviews yet.